BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo C, Zhang C, Xia Z, Song B, Hu W, Cui Y, Xue Y, Xia M, Xu D, Zhang S, Fang J. Nano-designed CO donor ameliorates bleomycin-induced pulmonary fibrosis via macrophage manipulation. J Control Release 2021;341:566-77. [PMID: 34864115 DOI: 10.1016/j.jconrel.2021.11.047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Wang Y, Xue Z, Wan W, Li Y, Qin H, Zhu Y, Tian F, Yang J. Magnetic liposome as a dual-targeting delivery system for idiopathic pulmonary fibrosis treatment. J Colloid Interface Sci 2023;636:388-400. [PMID: 36640550 DOI: 10.1016/j.jcis.2023.01.007] [Reference Citation Analysis]
2 Yang M, Lin Y, Han M, Bi Y, He X, Xing L, Jeong J, Zhou T, Jiang H. Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy. Journal of Controlled Release 2022;351:623-637. [DOI: 10.1016/j.jconrel.2022.09.054] [Reference Citation Analysis]
3 Xia Z, Zhang C, Guo C, Song B, Hu W, Cui Y, Xue Y, Xia M, Xu D, Zhang S, Fang J. Nanoformulation of a carbon monoxide releasing molecule protects against cyclosporin A-induced nephrotoxicity and renal fibrosis via the suppression of the NLRP3 inflammasome mediated TGF-β/Smad pathway. Acta Biomater 2022;144:42-53. [PMID: 35304324 DOI: 10.1016/j.actbio.2022.03.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]